Tower Research Capital (TRC)’s Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share SGHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-191
Closed 6761
2022
Q3
$0 Hold
191
﹤0.01% 6835
2022
Q2
$0 Hold
191
﹤0.01% 6903
2022
Q1
$1K Buy
+191
New +$334 ﹤0.01% 5981

Tower Research Capital (TRC)'s SGHC.WS Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share (SGHC.WS) in Q4 2022, closing a stake of 191 shares.

Tower Research Capital (TRC) first reported a position in SGHC.WS in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 0 funds tracked by Wall St. Rank hold SGHC.WS as of Q4 2022.

  • Tower Research Capital (TRC) reported no remaining Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share position as of Q4 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 191 Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share shares in Q4 2022.
  • Tower Research Capital (TRC) first reported a position in Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share in Q1 2022 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share position peaked at $1K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.